Work

A randomized trial of sodium alginate prevention of radiation-induced esophagitis in patients with locally advanced NSCLC receiving concurrent chemoradiotherapy: OLCSG1401

Year: 2019

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdz265.052

Authors: T. Yokoyama, K. Ninomiya, I. Oze, T. Hata, A. Tanaka, A. Bessho, S. Hosokawa, S. Kuyama, K. Kudo, T. Kozuki, D. Harada, M. Yasugi, T. Murakami, M. Nakanishi, N. Takigawa, K. Katsui, Y. Maeda, K. Hotta, K. Kiura

Institutions: Kurashiki Central Hospital, Okayama University, Aichi Cancer Center, Okayama Red Cross General Hospital, Iwakuni Medical Center, Shikoku Cancer Center, Chugoku Central Hospital, Onomichi General Hospital, National Sanyo Hospital, Kawasaki Medical School, Okayama University Hospital

Language: English

Topic: Esophageal Cancer Research and Treatment

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, Taiho Pharmaceutical, Boehringer Ingelheim Japan, Daiichi-Sankyo, Kyowa Hakko Kirin, Astellas Pharma, Shionogi, Ono Pharmaceutical, Chugai Pharmaceutical, MSD K.K., Eli Lilly Japan, Bayer Yakuhin, Daiichi Sankyo Europe

OpenAlex ID: W2978468976

FWCI: 0.235

Cites:

Cited by: 1

Related to: 10